Femoxetine
Femoxetine is a serotonin reuptake inhibitor (SRI) that was developed by Pfizer in the 1970s for the treatment of depression. Despite showing promise in clinical trials, it was never marketed.
History[edit]
Femoxetine was first synthesized by Pfizer in the 1970s as part of a research program aimed at developing new antidepressant medications. Early clinical trials suggested that it was effective in treating depression, but further development was halted for unknown reasons.
Pharmacology[edit]
As a serotonin reuptake inhibitor, femoxetine works by increasing the levels of serotonin in the brain. Serotonin is a neurotransmitter that is involved in regulating mood, and increasing its levels can help to alleviate the symptoms of depression.
Clinical Trials[edit]
In the clinical trials that were conducted, femoxetine was found to be effective in treating depression. However, the trials were small and further research is needed to confirm these findings.
Current Status[edit]
Despite the promising results from the clinical trials, femoxetine was never marketed. The reasons for this are not clear, but it may be due to the development of other, more effective antidepressants.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
